)
AstraZeneca Pharma India has scaled the Rs 1,000 mark after entering into an agreement with AstraZeneca UK. The stock is going strong at Rs 1010, up 8.3%, on the BSE.
AstraZeneca Pharma India has entered into agreement dated 24 March 2015 with AstraZeneca UK (AZ UK). A per the terms of the understanding, the company would receive from AZ UK, the reimbursement of certain costs incurred for the marketing and promotion of the new launch products and support for the distribution of other products supplied by AZ UK, in accordance with the arm's length return on revenues, said a company release.
AstraZeneca Pharma India is a leading pharma company, with a broad range of medicines designed to fight disease in important areas of healthcare.
The stock opened at Rs 952 and has touched a high of Rs 1,028 and a low of Rs 944 thus far.
